phenylbutazone often referred nonsteroidal antiinflammatory drug nsaid shortterm treatment pain fever animals united states united kingdom longer approved human use except united kingdom ankylosing spondylitis cause severe adverse effects suppression white blood cell production aplastic anemia drug implicated meat adulteration scandal positive phenylbutazone tests horse meat uncommon uk phenylbutazone originally made available use humans treatment rheumatoid arthritis gout however longer approved therefore marketed human use united uk used treat ankylosing spondylitis therapies phenylbutazone commonly used nsaid horses united used following purposes kentucky derby dancers image winner race disqualified traces phenylbutazone allegedly discovered postrace urinalysis owned prominent massachusetts businessman peter fuller ridden jockey bobby ussery dancers image first horse win kentucky derby disqualified phenylbutazone legal tracks around united states yet approved churchill downs controversy speculation still surround incident weeks prior race fuller given previous winnings coretta scott king widow slain civil rights activist martin luther king jr brought praise criticism previous year king held sitin housing discrimination disrupted derby week forty years later fuller still believed dancers image disqualified due although forward pass named winner many appeals kentucky derby official website lists dancers image forward pass winner websites race video commentary states winners plaque churchill downs dancers image forward pass listed winner kentucky phenylbutazone occasionally used dogs longerterm management chronic pain particularly due osteoarthritis adult dogs affected osteoarthritis makes management musculoskeletal pain major component companion animal practice margin safety nsaids narrow dog nsaids commonly used etodolac carprofen gastrointestinalprotectant drugs misoprostol cimetidine omeprazole ranitidine sucralfate frequently included part treatment nsaid dogs receiving chronic phenylbutazone therapy followed regular blood work renal side effects phenylbutazone dogs include gastrointestinal gi ulceration bone marrow depression rashes malaise blood dyscrasias diminished renal blood flow phenylbutazone plasma elimination halflife hours however inflammatory exudate half life single daily dosing sufficient although often used twice per drug considered fairly nontoxic given appropriate doses mgkgday even used dose doubled diseases cause severe pain laminitis toxic repeated longterm exceptionally high doses mgkgd higher kill animal less phenylbutazone administered orally via paste powder feedin intravenously given intramuscularly injected place vein cause tissue damage tissue damage edema may also occur drug injected repetitively vein side effects phenylbutazone similar nsaids overdose prolonged use cause gastrointestinal ulcers blood dyscrasia kidney damage primarily dosedependant renal papillary necrosis oral lesions given mouth internal especially pronounced young ill stressed horses less able metabolize effects gastrointestinal damage include edema legs belly secondary leakage blood proteins intestines resulting decreased appetite excessive thirst weight loss weakness advanced stages kidney failure death phenylbutazone also cause agranulocytosis phenylbutazone amplifies anticoagulant effect vitamin k antagonists warfarin phenprocoumon phenylbutazone displaces warfarin plasma binding sites toxic blood levels leading haemorrhage occur may aggravate kidney liver problems phenylbutazone may toxic embryo transferred via umbilical cord milk phenylbutazone used foals premature foals septicemic foals foals questionable kidney liver function foals diarrhea require careful monitoring drugs protect gi tract omeprazole cimetidine sucralfate frequently used phenylbutazone high doses phenylbutazone may considered rules violation equestrian organizations drug may remain bloodstream four five days administration international agency research cancer places group ie classifiable carcinogenicity humans use horses limited intended food metabolites phenylbutazone cause aplastic anaemia opinions conflicting regarding carcinogenicity phenylbutazone animals evidence indicates causes cancer humans therapeutic doses maekawa et al found increased cancer incidence donryu rats fed diet containing phenylbutazone two hand kari et al found rare type kidney cancer rats increased rate liver cancer male rats fed mgkg body weight phenylbutazone two tennant listed phenylbutazone nonmutagenic kirkland fowler acknowledged phenylbutazone predicted mutagen computer software simulates chemicals interaction one laboratory study indicated phenylbutazone subtly altered structure chromosomes bone marrow cells kirkland fowler furthermore explained theoretical carcinogenic effects phenylbutazone humans studied patients prescribed drug given doses far level effect may become apparent world health organizations international agency research cancer iarc stated inadequate evidence carcinogenic effect antiinflammatory drugs tend cause gi ulcers corticosteroids nsaids potentiate bleeding risk combination anticoagulant drugs particularly coumarin derivatives also increases risk bleeding avoid combining hepatotoxic drugs phenylbutazone may affect blood levels duration action phenytoin valproic acid sulfonamides sulfonylurea antidiabetic agents barbiturates promethazine rifampicin chlorpheniramine diphenhydramine penicillin overdoses phenylbutazone cause kidney failure liver injury bone marrow suppression gastric ulceration perforation early signs toxicity include loss appetite phenylbutazone crystalline substance obtained condensation diethyl nbutylmalonate hydrazobenzene presence base effect represents formation heterocyclic system simple lactamization hydrazobenzene diethyl nbutylmalonate oxyphenbutazone major metabolite phenylbutazone differs para location one phenyl groups hydrogen atom replaced hydroxyl group making httpsenwikipediaorgwikiphenylbutazone